Dynavax Technologies
Yahoo Finance • 3 months ago
Federated Hermes, Inc. Reduces Stake in Dynavax Technologies Corp
Overview of the Recent Transaction On August 31, 2024, Federated Hermes, Inc., a prominent investment firm, executed a significant transaction involving the shares of Dynavax Technologies Corp (NASDAQ:DVAX). The firm reduced its holdings... Full story
Yahoo Finance • 7 months ago
Analysts Are Updating Their Dynavax Technologies Corporation (NASDAQ:DVAX) Estimates After Its First-Quarter Results
Dynavax Technologies Corporation (NASDAQ:DVAX) just released its latest first-quarter report and things are not looking great. Revenues missed expectations somewhat, coming in at US$51m, but statutory earnings fell catastrophically short,... Full story
Yahoo Finance • 7 months ago
Dynavax Technologies First Quarter 2024 Earnings: Misses Expectations
Dynavax Technologies (NASDAQ:DVAX) First Quarter 2024 Results Key Financial Results Revenue: US$50.8m (up 8.2% from 1Q 2023). Net loss: US$8.72m (loss narrowed by 64% from 1Q 2023). US$0.067 loss per share (improved from US$0.19 loss in... Full story
Yahoo Finance • 8 months ago
11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Be... Full story
Yahoo Finance • 10 months ago
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference
EMERYVILLE, Calif., Feb. 27, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will prese... Full story
Yahoo Finance • 10 months ago
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript February 22, 2024 Dynavax Technologies Corporation isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details... Full story
Yahoo Finance • last year
Insider Sell: President & COO David Novack Sells 20,000 Shares of Dynavax Technologies Corp
On November 1, 2023, David Novack, President & COO of Dynavax Technologies Corp (NASDAQ:DVAX), sold 20,000 shares of the company. This move is part of a larger trend for the insider, who over the past year has sold a total of 189,719 share... Full story
Yahoo Finance • last year
10 Best Revenue Growth Stocks to Buy
In this piece, we will take a look at the ten best revenue growth stocks to buy. If you want to skip over the latest news for the stock market and want to jump ahead to the top five stocks in this list, then take a look at 5 Best Revenue G... Full story
Yahoo Finance • last year
Chuck Royce Portfolio, Performance and Net Worth
In this piece, we will take a look at millionaire Chuck Royce's investment portfolio, his net worth and the overall performance of the stocks. If you want to skip our introduction of the investor, his trading strategy, and details about hi... Full story
Yahoo Finance • 2 years ago
Valneva Provides Clinical and Regulatory Updates for its COVID-19 Vaccine VLA2001
Saint-Herblain(France), March 2, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced additional data from remaining clinical studies and an update on regulatory submissions for its inactivate... Full story
Yahoo Finance • 2 years ago
Valneva fournit des informations cliniques et règlementaires concernant son vaccin contre la COVID-19 VLA2001
Saint-Herblain (France), 2 mars 2023 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, annonce aujourd'hui de nouvelles données pour son vaccin contre la COVID-19, VLA2001, provenant d’études cliniq... Full story
Yahoo Finance • 2 years ago
13 High Growth Pharma Stocks that are Profitable
In this piece, we will take a look at 13 high growth pharma stocks that are profitable. For more stocks, head on over to 5 High Growth Pharma Stocks that are Profitable. One industry that has rapidly evolved with time and impacted million... Full story
Yahoo Finance • 2 years ago
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023
-- China commercial launch in multiple provinces and municipalities expected to begin in Q1 2023, and Clover anticipates a significant and sustained long-term annual booster market for its premium, broadly protective protein-based COVID-19... Full story
Yahoo Finance • 2 years ago
Valneva Reports Further Heterologous Booster Data for its inactivated COVID-19 vaccine
Saint-Herblain (France),December30,2022 – ValnevaSE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further heterologous booster data from an exploratory, small clinical study for its inactivated COVID-19 v... Full story
Yahoo Finance • 2 years ago
Valneva annonce de nouvelles données de rappel hétérologue pour son vaccin inactivé contre la COVID-19
Saint-Herblain (France), le 30 décembre2022 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, annonce aujourd'hui la publication de nouvelles données provenant d’une petite étude exploratoire portan... Full story
Yahoo Finance • 2 years ago
Clover’s Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases
-- The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum... Full story
Yahoo Finance • 2 years ago
10 Best Vaccine Stocks To Buy Now
In this article, we will discuss the 10 best vaccine stocks to buy now. If you want to explore similar stocks, you can also take a look at 5 Best Vaccine Stocks To Buy Now. One of the most defensive areas of the market is healthcare, and... Full story
Yahoo Finance • 2 years ago
Clover Provides Update on 2022 Corporate Milestones
-- Significant progress made on regulatory submissions to the China NMPA, the EMA, and the WHO for Clover’s lead COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum), with completion anticipated in Q4 2022 -- -- New data demonstrating sup... Full story
Yahoo Finance • 2 years ago
Valneva Announces Publication of its COVID-19 Vaccine Phase 3 Data in The Lancet Infectious Diseases
Saint-Herblain (France), September6, 2022 – ValnevaSE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that The Lancet Infectious Diseases (“The Lancet ID”), a peer-reviewed medical journal, has published t... Full story
Yahoo Finance • 2 years ago
Valneva annonce la publication dans le Lancet Infectious Diseases des résultats de Phase 3 pour son vaccin contre la COVID-19
Saint-Herblain (France), le 6 septembre 2022 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, annonce aujourd'hui que la revue médicale Lancet InfectiousDiseases ("le Lancet") a publié des données... Full story
